Clinical Trials Logo

Non-melanomatous Skin Cancer clinical trials

View clinical trials related to Non-melanomatous Skin Cancer.

Filter by:

NCT ID: NCT00017485 Completed - Clinical trials for Non-melanomatous Skin Cancer

Photodynamic Therapy in Treating Patients With Basal Cell Skin Cancer

Start date: January 2000
Phase: Phase 1
Study type: Interventional

RATIONALE: Photodynamic therapy uses light and drugs that make cancer cells more sensitive to light to kill tumor cells. Photosensitizing drugs such as HPPH are absorbed by cancer cells and, when exposed to light, become active and kill the cancer cells. PURPOSE: Phase I trial to study the effectiveness of photodynamic therapy with HPPH in treating patients who have basal cell skin cancer.

NCT ID: NCT00006361 Completed - Clinical trials for Head and Neck Cancer

SU5416 in Treating Patients With Advanced or Recurrent Cancer of the Head and Neck

Start date: December 2000
Phase: Phase 2
Study type: Interventional

RATIONALE: SU5416 may stop the growth of cancer cells by stopping blood flow to the tumor. PURPOSE: Phase II trial to study the effectiveness of SU5416 in treating patients who have advanced or recurrent cancer of the head and neck.

NCT ID: NCT00005884 Completed - Clinical trials for Non-melanomatous Skin Cancer

Eflornithine to Prevent Skin Cancer in Patients With Previously Treated Early Stage Skin Cancer

Start date: n/a
Phase: Phase 3
Study type: Interventional

RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development or recurrence of cancer. The use of eflornithine may be an effective way to prevent the recurrence of or further development of skin cancer. PURPOSE: Randomized phase III trial to determine the effectiveness of eflornithine in preventing skin cancer in patients who have previously received treatment for early stage skin cancer.

NCT ID: NCT00005097 Terminated - Clinical trials for Non-melanomatous Skin Cancer

Green Tea Extract in Treating Patients With Actinic Keratosis

Start date: August 1999
Phase: Phase 2
Study type: Interventional

RATIONALE: Green tea extract contains ingredients that may inhibit the growth of actinic keratosis. PURPOSE: Randomized phase II trial to determine the effectiveness of green tea extract in treating patients who have actinic keratosis.

NCT ID: NCT00003611 Completed - Clinical trials for Non-melanomatous Skin Cancer

Acitretin in Preventing Skin Cancers in Patients With Previously Treated Skin Cancers Who Have Undergone Organ Transplantation

Start date: May 2000
Phase: N/A
Study type: Interventional

RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development or recurrence of cancer. The use of acitretin may be an effective way to prevent the recurrence or further development of skin cancer. PURPOSE: Randomized clinical trial to study the effectiveness of acitretin in preventing skin cancers in patients with at least two previously treated skin cancers who have undergone organ transplantation.

NCT ID: NCT00003097 Active, not recruiting - Clinical trials for Non-Melanomatous Skin Cancer

Low Fat Diet to Prevent Disease Progression in Patients With Skin Cancer

Start date: April 1989
Phase: Phase 2
Study type: Interventional

RATIONALE: A low-fat, balanced diet may prevent disease progression in patients with nonmelanomatous skin cancer. PURPOSE: Randomized phase II trial to study the effectiveness of a low-fat, balanced diet to prevent disease progression in patients with nonmelanomatous skin cancer.

NCT ID: NCT00002975 Completed - Clinical trials for Precancerous Condition

Photodynamic Therapy in Treating Patients With Skin Cancer

Start date: February 1997
Phase: Phase 2
Study type: Interventional

RATIONALE: Photodynamic therapy uses light and drugs that make cancer cells more sensitive to light to kill tumor cells. Photodynamic therapy using aminolevulinic acid may be effective in treating patients with skin cancer. PURPOSE: This randomized phase II trial is studying how well photodynamic therapy that includes aminolevulinic acid works in treating patients with skin cancer.

NCT ID: NCT00002963 Completed - Clinical trials for Non-melanomatous Skin Cancer

Photodynamic Therapy in Treating Patients With Skin Cancer

Start date: November 1993
Phase: Phase 2
Study type: Interventional

RATIONALE: Photodynamic therapy uses light and drugs that make cancer cells more sensitive to light to kill tumor cells. Photodynamic therapy using aminolevulinic acid cream may be effective in treating patients with skin cancer. PURPOSE: This randomized phase II trial is studying how well photodynamic therapy works in treating patients with skin cancer.

NCT ID: NCT00002506 Completed - Lung Cancer Clinical Trials

Isotretinoin Plus Interferon in Treating Patients With Recurrent Cancer

Start date: August 1992
Phase: Phase 2
Study type: Interventional

RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development or recurrence of cancer. The use of isotretinoin may be an effective way to prevent cancer or stop cancer from growing. Interferon alfa may interfere with the growth of cancer cells. Combining isotretinoin and interferon may be an effective treatment for some recurrent cancers. PURPOSE: Phase II trial to study the effectiveness of interferon alfa plus isotretinoin in treating patients with recurrent cancer.